Почетна › Глиобластом › Тексас › Houston
Kliničke studije za Глиобластом u gradu Houston, TX
27 studija za Глиобластом traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Тражи се учесникФаза 2
- UT MD Anderson Cancer Center, Houston
A Phase I Clinical Study of YN003 in the Treatment of Glioma
Тражи се учесникФаза 1
- The University of Texas MD Anderson Cancer Center, Houston
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Тражи се учесникФаза 3
- Houston Methodist, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Тражи се учесникФаза 1
- The University of Texas MD Anderson Cancer Center, Houston
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Тражи се учесникФаза 1
- MD Anderson Cancer Center, Houston
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Тражи се учесникФаза 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Тражи се учесникФаза 1/2
- MD Anderson Cancer Center, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Тражи се учесникФаза 3
- MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Тражи се учесникФаза 1
- Baylor St. Luke's Medical Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Тражи се учесникФаза 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Тражи се учесникФаза 1
- M D Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Тражи се учесникОпсервациона студија
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Тражи се учесникФаза 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Тражи се учесникФаза 2
- Texas Children's Hospital, Houston
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Тражи се учесникФаза 1
- MD Anderson Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Тражи се учесникФаза 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Тражи се учесникФаза 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
Тражи се учесникЗдраве особе су добродошле
- M D Anderson Cancer Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Тражи се учесникФаза 2
- M D Anderson Cancer Center, Houston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Тражи се учесникФаза 2
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Тражи се учесникРана фаза 1Здраве особе су добродошле
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Тражи се учесникФаза 2
- Texas Children's Hospital, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Тражи се учесникФаза 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Тражи се учесникФаза 1/2
- Houston Methodist Neurological Institute, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Тражи се учесникФаза 1/2
- MD Anderson Cancer Center, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Тражи се учесникФаза 1
- UT MD Anderson Cancer Center, Houston
Studije za Глиобластом u drugim gradovima
- New York City, NY30 студија
- Boston, MA27 студија
- Los Angeles, CA23 студија
- Durham, NC19 студија
- San Francisco, CA19 студија
- Chicago, IL15 студија
- Rochester, MN14 студија
- Washington, DC14 студија
- Columbus, OH14 студија
- Miami, FL14 студија
- Jacksonville, FL13 студија
- Cleveland, OH12 студија
Ostale studije u gradu Houston
- Немалоклетни карцином плућа143 студија
- Рак дојке126 студија
- Рак (све врсте)124 студија
- Колоректални карцином101 студија
- Метастатски карцином100 студија
- Рак јајника90 студија
- Akutna mijeloidna leukemija88 студија
- Рак плућа78 студија
- Рак простате73 студија
- Карцином ендометријума69 студија
- Меланом61 студија
- Рак панкреаса59 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.